Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
09/2005
09/21/2005EP1575953A1 Anhydrous crystalline form of valacyclovir hydrochloride
09/21/2005EP1575934A1 Carbazole derivatives and their use as npy-5 antagonists
09/21/2005CN1671734A CFTR modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
09/21/2005CN1671716A Method of treating ischemia reperfusion injury using adenosine receptor antagonists
09/21/2005CN1671390A Adenosine A2A receptor antagonists for treating restless legs syndrome or related disorders
09/21/2005CN1670020A Pyrazopyrimidinone compounds and use thereof
09/20/2005US6946478 Compounds
09/20/2005US6946449 5*-sulfoxy-adensoine derivatives used to treat tachycardia and atrial flutter, angina, and myocardial infarction
09/20/2005CA2189088C 2-amino-6-chloropurine and method for preparing the same
09/15/2005WO2005085470A1 Specific substrates for o6- alkylguanine-dna alkyltransferase
09/15/2005WO2005085247A1 Crystalline forms of valacyclovir hydrochloride
09/15/2005WO2005085246A1 8-[3-amino-piperidin-1-yl]-xanthine, the production thereof and the use in the form of a dpp inhibitor
09/15/2005WO2005000404A3 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
09/15/2005WO2004069168A3 Novel antiherpes drug combinations
09/15/2005US20050203147 Biaryl heterocyclic compounds and methods of making and using the same
09/15/2005US20050203107 Reversible inhibitors of cysteine proteases S, K, F, L and B; inhibiting Cathepsin S; analgesics; 1-[9-(4-Chlorophenyl)-2-cyano-9H-purin-6-yl]-L-prolinamide for example
09/15/2005US20050203065 Use of A2b adenosine receptor antagonists such as 3-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2]oct-1-yl]-propionic acid (BG 9928)
09/15/2005CA2557667A1 Aryl substituted purine analogues
09/15/2005CA2556991A1 Crystalline forms of valacyclovir hydrochloride
09/15/2005CA2555050A1 8-[3-amino-piperidin-1-yl]-xanthine derivatives, the production thereof and the use in the form of a dpp-iv inhibitor
09/14/2005EP1529048A4 Methods for the synthesis of substituted purines
09/14/2005EP1068209B1 Process for the production of purine derivatives and intermediates therefor
09/14/2005EP0970081B1 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
09/14/2005CN1669183A Method and unit for beam control of antenna array
09/14/2005CN1668618A Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof
09/14/2005CN1668615A Novel benzimidazole derivatives
09/14/2005CN1666742A Combination therapy to treat hepatitis b virus
09/13/2005US6943175 Nitrogen compounds such as N-(3,5-dibromobenzyl)-N'-(1H-imidazo[4,5-b]pyridin-2-yl)-propane-1,3-diamine, used as inhibitors of methionyl transfer RNA synthetases in bacteria; antibiotics; bactericides
09/13/2005CA2244680C Process for preparing purine derivatives
09/09/2005WO2005082906A1 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof, and the use of the same as medicaments
09/09/2005WO2005082896A1 Nucleoside analogues with antiviral activity
09/09/2005WO2005063766A3 Bicyclic heterocyclic p-38 kinase inhibitors
09/09/2005WO2005051286A3 Stable ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-yloxy) methyl)-2-amine-1h-purin-6(9h)-one.
09/09/2005CA2556064A1 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof, and the use of the same as medicaments
09/08/2005US20050197371 Urea derivatives as PDGFR modulators
09/08/2005US20050197328 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent
09/08/2005DE102004009039A1 8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel 8- [3-amino-piperidin-1-yl] -xanthines, their preparation and use as medicaments
09/07/2005EP1368342B1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
09/07/2005CN1665814A Synthesis of purine derivatives
09/06/2005US6939965 Process of manufacture of 1,3-oxathiolane nucleosides using titanium trichloride mono-isopropoxide
09/06/2005US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
09/01/2005WO2005080394A1 4-substituted piperidine derivatives
09/01/2005WO2005080348A1 Novel sulfone amide derivative
09/01/2005WO2005080330A1 Heteroarylphenylurea derivative
09/01/2005WO2004110343A3 2-amino-9-(2-substituted ethyl)purines and preparing methods for 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]- 2- aminopurine using the same
09/01/2005US20050192314 Use of urea derivatives of isoxazoles; c-kit kinase inhibitors; anticancer agents; leukemias such as acute myelogenous leukemia (AML), and chronic myelogenous leukemias (CMLs)
09/01/2005US20050192296 Reacting a selected tert-butoxy-valine with acyclovir in an organic solvent to obtain a mixture,combining with 4-dimethylaminopyridine, water to obtain a precipitate; removing the precipitate, concentrating the resulting filtrate, deprotecting in formic acid, water and HCl to obtain salt form
09/01/2005US20050190182 Data-driven layout engine
09/01/2005DE102004008112A1 New 8-aminopiperidinyl-xanthine derivatives, useful for treating e.g. diabetes, arthritis and osteoporosis, are inhibitors of dipeptidylpeptidase-IV
09/01/2005CA2556589A1 4-substituted piperidine derivatives
09/01/2005CA2555409A1 Novel sulfone amide derivative
08/2005
08/31/2005EP1568699A1 1,3-dihydroimidazole fused-ring compound
08/31/2005EP1221444B1 Fused imidazole compounds and remedies for diabetes mellitus
08/31/2005EP1050525B1 Substances capable of inducing apoptosis
08/31/2005CN1662536A Alkynylpurine compounds and production methods thereof
08/31/2005CN1660849A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/31/2005CN1660846A Entecavir in non crystallization kenel
08/31/2005CN1660839A Chemical compounds
08/30/2005US6936713 Process for producing 2,6-dihalogenopurine
08/30/2005US6936615 Heteroaryl derivatives and their use as medicaments
08/25/2005WO2005077950A2 Medicaments with hm74a receptor activity
08/25/2005WO2005000850A3 Novel crystalline forms of valacyclovir hydrochloride
08/25/2005WO2004069394A3 Synthetic method for direct arylation of heterocyclic arenes
08/25/2005US20050187229 Crystalline forms of valacyclovir hydrochloride
08/25/2005US20050187228 Derivatives of purine, their preparation process and pharmaceutical compositions containing them
08/25/2005US20050187227 8-[3-Amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical composition
08/25/2005US20050187226 A1 adenosine receptor antagonists
08/25/2005US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability;
08/24/2005EP1565470A2 Process for the preparation of ganciclovir
08/24/2005EP1565469A1 Process for the synthesis of ganciclovir
08/24/2005EP1565468A1 Novel xanthin derivatives, production and use thereof as medicaments
08/24/2005EP1565192A2 Method and compositions for temporarily incapaciting subjets
08/24/2005EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
08/24/2005EP0804436B1 Guanine derivative
08/24/2005CN1659168A Amide substituted xanthine derivatives with gluconeogenesis modulating activity
08/24/2005CN1659153A PNA monomer and precursor
08/24/2005CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
08/24/2005CN1216046C Improved methods of synthesis for 9-substituted hypoxanthine derivatives
08/23/2005US6933295 Substituted isoindoles and the use thereof
08/18/2005WO2005074654A2 Methods to manufacture 1,3-dioxolane nucleosides
08/18/2005US20050182077 8-amino-7-substituted-2,6-dioxo-1,2,3,6-tetrahydro-7H-purines; erectile dysfunction; sexual disorders; psychological disorders; hypotensive agents; restenosis; cardiovascular disorders; antidiabetic agents; vision defects; autoimmune diseases; anticancer agents
08/18/2005US20050182075 For prophylaxis and therapy of hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant
08/18/2005CA2554782A1 Methods to manufacture 1,3-dioxolane nucleosides
08/17/2005EP1562946A1 Novel xanthine derivatives, the production and the use thereof in the form of drugs
08/17/2005CN1656227A Thermolabile caffeine fraction of tea leaves and an efficient method of introducing agrobacterium-mediated genetic transformation in plants
08/17/2005CN1656097A Xanthine phosphodiesterase V inhibitor polymorphs
08/17/2005CN1656071A New piperidine derivative
08/17/2005CN1215061C Process for preparing anticancer compound, and intermediate
08/16/2005US6930113 For therapy and prophylaxis of sexual dysfunctios; hypertension, pulmonary hypertension, congestive heart failure, renal failure, myocardial infraction, stable, unstable and variant (Prinzmetal) angina, atherosclerosis
08/11/2005WO2005073233A1 Process for the preparation of valacyclovir hydrochloride
08/11/2005WO2005072739A1 Drug for treating migraine
08/11/2005WO2005058898A3 Purine compounds which can be used as phosphodiesterase (pde) type iv inhibitors
08/11/2005US20050176956 Process for the preparation of ganciclovir intermediate n2-acetyl-9-(1,3-diacetoxy-2-propoxymethyl) guanine
08/11/2005US20050176939 Using temperature variation to isolate epigallocatechin (EGC) and epigallocatechin gallate (EGCG) from green and/or white tea
08/11/2005US20050176744 nitrogen heterocyclyl-(thio)carbonyl- quinoline derivatives used for treating cervical carcinoma or ovarian adenocarcinoma
08/11/2005US20050176739 Xanthine derivatives; adenosine receptor antagonists; anorexia; 8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine
08/11/2005US20050176707 Compositions and methods for inducing cell dedifferentiation
08/11/2005US20050176701 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
08/11/2005CA2552560A1 Process for the preparation of valacyclovir hydrochloride
08/10/2005EP1561752A1 Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 120